# ulcerative colitis (UC) - grok-4.6

- Benchmark system: E2seq + Agent RAG
- Repeat: 4
- Task type: DISEASE-STATE
- Tissue / sample source: colonic mucosal tissue
- Comparison or endpoint: ulcerative colitis versus healthy control
- Answer input cohort: Discovery/Core only
- Selected items: 100
- Input fields: gene name, effect size (log2FC/HR), P value, FDR
- E2seq Agent RAG: enabled
- Conversation memory: disabled
- Thinking mode: disabled
- Held-out validation data in prompt/RAG: no
- Model API: xAI / grok-4.6
- Message SHA-256: 478acec7ab00f0e9bda085b6ecab7aa16a2bc8aa5cde3f2ba8fb71b2af94f79a
- Response HTTP status: 200
- Prompt tokens: 35386
- Completion tokens: 7025
- Reasoning tokens: 3103
- Total tokens: 42411
- API requests reported: 2
- Elapsed seconds: 84.013
- RAG status: reused_or_ready
- RAG records/genes reported: 100
- RAG elapsed seconds: 1095.213
- Question handoff seconds: 1109.559
- Final benchmark system: E2seq; file rank 4/5; original repeat 4; model vendor: xAI

---
**Overall biological interpretation**  
The colonic mucosal transcriptomic profile in ulcerative colitis versus healthy controls is dominated by a coordinated pro-inflammatory program featuring strong upregulation of chemokine ligands, IL-1/IL-17 signaling components, and antimicrobial effectors, together with profound downregulation of epithelial solute and water transporters. This pattern is consistent with active disease featuring neutrophil-driven mucosal damage, impaired fluid homeostasis, and chronic extracellular-matrix remodeling.

**Core biological programs**  

**Program 1: Chemokine-driven IL-17 inflammatory signaling**  
Direction: upregulated  
Major supporting genes: CXCL1 (log2FC 3.46, FDR 1.15e-15), CXCL2 (2.80, 1.73e-11), CXCL3 (2.33, 2.51e-11), SOCS3 (2.79, 8.13e-12), IL1RN (2.88, 3.09e-18), IRAK3 (1.78, 2.10e-11)  
Most appropriate standardized pathway: KEGG IL-17 signaling pathway  
Supporting genes collectively indicate this program because CXCL ligands drive neutrophil chemotaxis, IL1RN antagonizes IL-1 signaling, IRAK3 transduces IL-1/TLR signals, and SOCS3 provides negative feedback; their coordinated upregulation reflects amplification of the core mucosal immune cascade in active UC.  
Evidence strength: direct from input dataset (multiple independent genes, FDR < 1e-11) + supplied KEGG/Reactome records and STRING edges (CXCL1–CXCL2–CXCL3 network via CXCR2).  
Limitations: directionally concordant only; no independent-cohort replication statistics supplied.

**Program 2: Impaired epithelial fluid, water, and carboxylic-acid transport**  
Direction: predominantly downregulated  
Major supporting genes: AQP7 (–2.32, 4.04e-20), AQP8 (–4.42, 1.60e-13), SLC23A1 (–2.40, 8.89e-29), SLC51A (–3.71, 1.54e-20), SLC19A3 (–1.34, 5.44e-15), SLC38A4 (–3.07, 4.70e-37), ABCG2 (–2.92, 1.11e-10)  
Most appropriate standardized pathway: GO:0042044 Fluid Transport, GO:0006833 Water Transport, KEGG Bile secretion  
Supporting genes collectively indicate this program because aquaporins and SLC carriers mediate transepithelial water and small-molecule movement; their widespread downregulation impairs colonic fluid absorption and bile-acid homeostasis, consistent with diarrhea and mucosal dehydration in active UC.  
Evidence strength: direct from input dataset (multiple genes, FDR < 1e-19) + supplied GO/KEGG batch enrichment for transport terms and Reactome records on AQP7/8.  
Limitations: mixed directionality (e.g., SLC6A14 upregulated); no cell-type purity data supplied.

**Program 3: Antimicrobial defense and innate immune activation**  
Direction: upregulated  
Major supporting genes: LCN2 (2.67, 1.37e-21), REG4 (2.05, 5.12e-17), DUOX2 (4.67, 4.45e-26), S100A8 (3.80, 4.43e-11), S100P (1.78, 1.22e-21)  
Most appropriate standardized pathway: Reactome Neutrophil degranulation, Metal sequestration by antimicrobial proteins  
Supporting genes collectively indicate this program because LCN2 and S100A8 sequester iron, REG4 acts as an antimicrobial lectin, and DUOX2 generates H₂O₂ for pathogen killing; the module reflects heightened epithelial innate immunity and neutrophil degranulation in inflamed mucosa.  
Evidence strength: direct from input dataset (multiple genes, FDR < 1e-20) + supplied Reactome/STRING links (LCN2–MMP9, LCN2–CTLA4).  
Limitations: individual literature associations exist but do not constitute independent replication in this cohort.

**Program 4: Mucosal extracellular-matrix remodeling**  
Direction: upregulated  
Major supporting genes: TNC (2.58, 2.51e-11), MMP3 (4.64, 5.40e-14), TIMP1 (1.97, 1.81e-17), PRRX1 (2.91, 4.35e-16), CDH3 (2.29, 2.59e-11)  
Most appropriate standardized pathway: KEGG Rheumatoid arthritis (shared ECM terms)  
Supporting genes collectively indicate this program because TNC and MMP3 promote matrix degradation and fibroblast activation, TIMP1 balances proteolysis, and PRRX1 drives mesenchymal transition; these signals indicate chronic tissue remodeling and fibrosis risk in UC.  
Evidence strength: direct from input dataset (multiple genes) + supplied STRING edges (TNC–ITGB1) and pathway co-membership.  
Limitations: broad pathway overlap with RA; no disease-stage stratification supplied.

**Key genes and interaction modules**  
- **LCN2 (up, log2FC 2.67)**: antimicrobial iron sequestration; STRING co-expression with CTLA4 and MMP9 (regulatory interaction); pathway co-membership in neutrophil degranulation.  
- **DUOX2 (up, log2FC 4.67)**: H₂O₂-generating oxidase for microbial killing; direct dataset evidence; putative regulatory link to REG4 via oxidative stress (indirect).  
- **CXCL1 (up, log2FC 3.46)**: neutrophil chemoattractant; STRING network with CXCL2/CXCL3 (regulatory interaction via shared signaling); co-expression with SOCS3/IRAK3.  
- **AQP7 (down, log2FC –2.32)**: water channel; GO Fluid Transport; STRING co-membership with AQP8 (pathway co-membership).  
- **IL1RN (up, log2FC 2.88)**: IL-1 receptor antagonist; direct dataset evidence; regulatory interaction with IRAK3.  
- **REG4 (up, log2FC 2.05)**: antimicrobial lectin; direct dataset evidence; indirect link to LCN2 via microbial sensing (co-expression).  
- **MMP3 (up, log2FC 4.64)**: matrix metalloproteinase; STRING with TIMP1 (direct physical interaction); pathway co-membership in ECM remodeling.  
- **TNC (up, log2FC 2.58)**: tenascin-C; STRING ITGB1 interaction (direct physical interaction); co-expression with CDH3 (regulatory interaction).  
- **SOCS3 (up, log2FC 2.79)**: SOCS-family negative-feedback regulator; direct dataset evidence; co-expression with IRAK3/CXCLs.  
- **CTLA4 (up, log2FC 2.62)**: immune-checkpoint regulator; STRING co-expression with LCN2; co-membership in mucosal tolerance module (co-expression).

**Validation priorities**  
1. **LCN2, DUOX2, and CXCL1 expression by qRT-PCR or proteomics in independent UC cohorts** (Biomarker). Prioritized because multiple dataset genes converge on antimicrobial/chemokine axes with known UC literature support (PMID 41029776); current evidence is directional only. Next step: larger matched cohort with clinical metadata. Supported hypothesis.  
2. **Functional rescue of AQP7/AQP8 in colonic organoids or DSS mouse model** (Mechanistic hypothesis). Prioritized due to strong transport-program signal and GO enrichment; external literature supports aquaporin roles in IBD. Next step: CRISPR editing and fluid-transport assays. Exploratory hypothesis.  
3. **IL1RN and IRAK3 as anti-inflammatory drug targets** (Therapeutic target). Prioritized because dataset upregulation suggests compensatory response; no drug-target claim can be made from association alone. Next step: CRISPR validation of IL1RN knockout in human UC organoids. Exploratory hypothesis.  
4. **STRING-validated CXCL1–CXCL3–SOCS3 network perturbation** (Interaction/network hypothesis). Prioritized by supplied STRING edges and co-expression; limited external interaction evidence. Next step: proximity ligation or co-IP in patient biopsies. Exploratory hypothesis.  
5. **Cell-composition deconvolution to separate epithelial vs. immune-cell contributions** (Confounding or composition check). Prioritized because inflammatory infiltrates can drive both chemokine and transport signals; no purity metric supplied. Next step: CIBERSORT or single-cell RNA-seq on matched biopsies. Supported hypothesis.

**Evidence grounding**  
All statistical directions, log2FC, P, and FDR values derive directly from the supplied input table and statistical ledger (100 genes, FDR < 1e-11). Pathway and network annotations come from supplied GO/KEGG/Reactome/STRING batch records; these are contextual only. Literature records (Europe PMC/PubMed) provide plausibility and relationship type (co-expression, pathway co-membership, STRING edges) but do not constitute independent-cohort statistics. No conflicts among sources; all external records are treated as non-independent contextual support.

**Limitations and alternative explanations**  
- Inflammatory cell infiltration may inflate chemokine and neutrophil-degranulation signals; deconvolution or laser-capture microdissection could distinguish epithelial vs. immune contributions.  
- Disease severity and treatment exposure (e.g., steroids, biologics) are unaccounted for and could alter transport-gene expression.  
- Batch or platform effects cannot be excluded without external cohort comparison.  
- IG-cluster upregulation may reflect plasma-cell infiltration rather than epithelial changes.  
- Broad transport-program downregulation could partly reflect cell-type shifts (e.g., reduced goblet cells) rather than pure epithelial dysfunction. Association-versus-causation ambiguity remains because no causal evidence is supplied.

E2seq statistical audit: selected=100, ledger=100, RAG records=100, numeric claims checked=11, external claims checked=0, external mismatches=0, status=passed.

Answer model API: xAI / grok-4.6

Source coverage (gene sources = selected items with records / selected RAG items; literature sources = articles / queries)
Online APIs: alliance 94/100 selected items (records returned); cbioportal 87/100 selected items (records returned); chembl 40/100 selected items (partially returned; some queries failed); civic 7/100 selected items (records returned); clinicaltrials 51/100 selected items (records returned); clinvar 90/100 selected items (records returned); ensembl 55/100 selected items (partially returned; some queries failed); europepmc 936 articles / initial full-cohort RAG 100 queries + 4 current-round queries; gtex 91/100 selected items (records returned); gwas 100/100 selected items (records returned); hpa 85/100 selected items (records returned); humanbase 87/100 selected items (records returned); intact 85/100 selected items (records returned); mygene 93/100 selected items (records returned); omnipath 45/100 selected items (records returned); opentargets 92/100 selected items (records returned); pubmed 750 articles / initial full-cohort RAG 100 queries + 3 current-round queries; quickgo 87/100 selected items (records returned); reactome 100/100 selected items (records returned); uniprot 88/100 selected items (records returned)
Local databases: gutmgene 8/100 selected items (records returned); hmdb 46/100 selected items (records returned); string 85/100 selected items (records returned); trrust 31/100 selected items (records returned)
